[HTML][HTML] Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient …
J Traeger-Synodinos, C Vrettou, C Sofocleous… - International Journal of …, 2024 - mdpi.com
In this short review, we presented and discussed studies on the expression of globin genes
in β-thalassemia, focusing on the impact of α-globin gene expression and α-globin modifiers …
in β-thalassemia, focusing on the impact of α-globin gene expression and α-globin modifiers …
[HTML][HTML] Association of ZBTB38 gene polymorphism (rs724016) with height and fetal hemoglobin in individuals with sickle cell anemia
DA Costa-Júnior, TNS Valente, AR Belisário… - Molecular Genetics and …, 2024 - Elsevier
Objectives Our study evaluated the association of the polymorphism rs724016 in the
ZBTB38 gene, previously associated with height in other populations, with predictors of …
ZBTB38 gene, previously associated with height in other populations, with predictors of …
Effective Utilization of Molecular Genetic Screening of Patients with Sickle Cell Disease and Beta Thalassemia Major in Saudi Arabia
R Zahed - 2023 - etheses.whiterose.ac.uk
Hereditary blood diseases are prevalent in the Kingdom of Saudi Arabia. The majority of
these blood disorders are sickle cell disease and β-thalassemia with variants located on the …
these blood disorders are sickle cell disease and β-thalassemia with variants located on the …
[HTML][HTML] Vaso-Occlusive Crises in Sickle Cell Trait Patients With Blood Loss Anemia: A Report of Two Cases
M Sabina, Z Barakat, JM Jost, R Tatro, W Sai - Cureus, 2024 - ncbi.nlm.nih.gov
This report of two cases confronts the longstanding perception of Sickle Cell Trait (SCT) as a
clinically benign condition, highlighting its complex and severe clinical manifestations …
clinically benign condition, highlighting its complex and severe clinical manifestations …
Progress And Challenges In Africa At The Time Of Molecular Haematology
L Luzzatto - Nigerian Journal of Haematology, 2023 - njhaem.org.ng
The study of blood diseases has been traditionally at the border between clinical medicine
and laboratory science. Many of us have been attracted to haematology by this combination …
and laboratory science. Many of us have been attracted to haematology by this combination …
Talasemia falciforme beta cero y síndrome torácico agudo en paciente pediátrico: Reporte de caso
DFL Muñoz, JEG Domínguez, ND Garcés… - Research, Society and …, 2024 - rsdjournal.org
The objective of this article is to report the case of a 5-year-old male patient diagnosed with
Sickle Beta Zero Thalassemia. An inherited disease that affects the hemoglobin of red blood …
Sickle Beta Zero Thalassemia. An inherited disease that affects the hemoglobin of red blood …
The Omic Modifiers of Morbidity and Mortality in Sickle Cell Disease
BM Lê - 2023 - search.proquest.com
Sickle cell disease (SCD) is a human genetic disorder caused by a mutation in the
hemoglobin beta gene, causing sickling of red blood cells (RBCs) under hypoxic conditions …
hemoglobin beta gene, causing sickling of red blood cells (RBCs) under hypoxic conditions …
[引用][C] Improving healthspan among people with sickle cell disease: Leveraging precision health in an era of treatments with curative intent
EA Yu, HU Zacharias, S Kelly… - American Journal of …, 2024 - Wiley Online Library
With the US Food and Drug Administration (FDA) approval of two new cell-based gene
therapies (Casgevy, Lyfgenia) for sickle cell disease (SCD) on December 8, 2023, 1 gene …
therapies (Casgevy, Lyfgenia) for sickle cell disease (SCD) on December 8, 2023, 1 gene …